2019 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2019-06-28±³À°ÀÏÀÚ : 2019-06-28
±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ
±³À°ÁÖÁ¦ :
2019 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 70,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 12:00~12:40 The evolving treatment landscape in ALK+NSCLC: the emerging role of brigatinib ÀÌ´ëÈ£(¿ï»êÀÇ´ë)
ÈÞ½Ä 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 12:40~13:00 Coffee Break ()
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 13:00~13:30 Targeted Agents in Lung Cancer ÃÖÀ±¶ó(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 13:30~14:00 Immuno-Oncology Agents in Lung Cancer °ÀºÁÖ(°í·ÁÀÇ´ë)
ÈÞ½Ä 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 14:00~14:20 Coffee Break ()
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 14:20~14:40 Radiotherapy for patients with underlying lung disease ±èÇÐÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 14:40~15:00 Management of radiation pneumonitis Á¤º´È£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 15:00~15:20 Emerging role of RT in stage IV lung cancer ¼¾ç±Ç(±¹¸³¾Ï¼¾ÅÍ)
ÈÞ½Ä 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 15:20~15:40 Coffee Break ()
Åä·Ð 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 15:40~16:15 Case Discussion (I): Practical approach to the patient with suspicious pleural metastasis ¾çÈñö(±¹¸³¾Ï¼¾ÅÍ)
Åä·Ð 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 16:15~16:50 Case Discussion (II): Practical approach to the patient with malignant pleural effusion ÇÏÁ÷ȯ(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 16:50~17:10 Coffee Break ()
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 17:10~17:30 Role for surgery in N2 nodes-positive lung cancer ±èÁø±¹(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 17:30~17:50 Systemic treatment for N2 non-small cell lung cancer ±è¿µ»ý(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06-28 ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 4Ãþ ÄÁº¥¼Ç Ȧ 17:50~18:05 ¼÷Á¦º¸°í Áö¿øÁØ(¿ï»êÀÇ´ë)